Detalles de la búsqueda
1.
Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions.
Curr Atheroscler Rep
; 20(7): 35, 2018 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29781057
2.
Correction to: Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions.
Curr Atheroscler Rep
; 20(9): 42, 2018 06 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29915890
3.
LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.
J Lipid Res
; 53(3): 556-560, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22236405
4.
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.
J Clin Lipidol
; 16(5): e77-e95, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36068139
5.
CD11c expression in adipose tissue and blood and its role in diet-induced obesity.
Arterioscler Thromb Vasc Biol
; 30(2): 186-92, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19910635
6.
Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.
Cardiovasc Drugs Ther
; 25(1): 59-67, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21416219
7.
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH).
J Clin Lipidol
; 15(5): 649-652, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34393074
8.
Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia.
Am Heart J
; 160(4): 759-66, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20934572
9.
Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.
Am J Cardiovasc Drugs
; 10(3): 175-86, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20524719
10.
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
Am J Cardiovasc Drugs
; 10(2): 73-84, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20136164
11.
A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 Studies.
Cardiol Ther
; 9(2): 447-465, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32564340
12.
The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy.
J Clin Lipidol
; 13(3): 415-424, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31113745
13.
Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.
Atherosclerosis
; 282: 52-56, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30685442
14.
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.
J Clin Lipidol
; 13(3): 374-392, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31147269
15.
Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
Am J Cardiol
; 101(12A): 41F-50F, 2008 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-18549871
16.
Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.
Am J Cardiol
; 101(3): 315-8, 2008 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18237592
17.
Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines.
Am J Cardiol
; 101(12A): 51F-57F, 2008 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-18549872
18.
Adjunctive interventions in myocardial infarction: the role of statin therapy.
Curr Atheroscler Rep
; 10(2): 142-8, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18417069
19.
Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet.
Clin Drug Investig
; 28(10): 615-23, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18783300
20.
Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.
Clin Drug Investig
; 28(10): 625-34, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18783301